FIA
ALZN icon

Foundations Investment Advisors’s Alzamend Neuro ALZN Stock Holding History

Foundations Investment Advisors’s Portfolio ALZN Stock Details ALZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-15
Closed -$4.74K – 669
2023
Q3 		$4.74K Buy
+15
New +$7.17K ﹤0.01% 638

Other funds holding ALZN

Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
RA
RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
HIA
Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return

Foundations Investment Advisors's ALZN Position: Q4 2023 in Review

Foundations Investment Advisors sold out of Alzamend Neuro (ALZN) in Q4 2023, closing a stake of 15 shares — an estimated $4.74K sold.

Foundations Investment Advisors first reported a position in ALZN in Q3 2023 and held it in 1 quarter. The position peaked at $4.74K in Q3 2023. 14 funds tracked by Wall St. Rank hold ALZN as of Q4 2023.

  • Foundations Investment Advisors reported no remaining Alzamend Neuro position as of Q4 2023 after selling out during the quarter.
  • Foundations Investment Advisors sold 15 Alzamend Neuro shares in Q4 2023, an estimated $4.74K.
  • Foundations Investment Advisors first reported a position in Alzamend Neuro in Q3 2023 and held it in 1 quarter.
  • Foundations Investment Advisors's Alzamend Neuro position peaked at $4.74K in Q3 2023.
  • 14 funds tracked by Wall St. Rank held Alzamend Neuro as of Q4 2023.

Based on Foundations Investment Advisors's 13F filing for Q4 2023, filed 8 Feb 2024.